Related Experiment Video
Updated: Apr 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis E: A disease of reemerging importance
Siddharth Sridhar1, Susanna K P Lau2, Patrick C Y Woo2
1Department of Microbiology, The University of Hong Kong, Hong Kong SAR, China.
Hepatitis E virus (HEV) is a global health concern, with increasing zoonotic transmission risks from animals. Recent advances offer better management for chronic cases and a vaccine for future control.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis E virus (HEV) is the leading cause of acute viral hepatitis globally.
- HEV and related viruses are now recognized to have diverse animal reservoirs, including dromedaries.
- Zoonotic transmission of HEV, particularly from foodborne sources like pigs and wild boar, is a growing concern in the Asia Pacific region.
Purpose of the Study:
- To review recent developments in the epidemiology of Hepatitis E virus.
- To highlight advancements in the treatment and management of chronic HEV infection.
- To discuss the prevention strategies and vaccine availability for Hepatitis E.
Main Methods:
- Literature review of recent studies on HEV epidemiology.
- Analysis of current treatment guidelines for chronic hepatitis E.
- Examination of vaccine efficacy and public health impact.
Main Results:
- HEV has expanded known animal reservoirs, increasing zoonotic potential.
- Zoonotic foodborne transmission is a significant factor in HEV spread, especially in developing regions.
- Progress has been made in managing chronic HEV, particularly in immunocompromised individuals.
Conclusions:
- Effective management strategies for chronic hepatitis E are now available.
- An approved vaccine offers a promising tool for controlling the global burden of Hepatitis E.
- Continued research into HEV ecology and transmission is crucial for public health.
Related Concept Videos
Hepatitis
Infectious Diseases and Their Occurrence
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Viral Recombination

